| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/05/2005 | CN1561197A Method for producing biologically active products |
| 01/05/2005 | CN1560266A Preparation process of rise bran polysaccharose kind active component |
| 01/05/2005 | CN1560041A Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 01/05/2005 | CN1559610A Vaccine curing for disease and its preparation method |
| 01/05/2005 | CN1559606A Cyclosporin A dispersion solid and its preparation method |
| 01/05/2005 | CN1559605A Compound aloe health-care tablet |
| 01/05/2005 | CN1559597A Disinfectant |
| 01/05/2005 | CN1559551A Immune regulation oral liquid |
| 01/05/2005 | CN1559545A Immune balancing energy restoring pill and its manufacturing method |
| 01/05/2005 | CN1559529A Medicine for treating urticaria |
| 01/05/2005 | CN1559449A Method for preparing oral liquid for treating prematophagoides farnae |
| 01/05/2005 | CN1559447A Extracte of Aspongopus chinensis Dallas and Extraction method therefor medicinal use and preparn. thereof |
| 01/05/2005 | CN1559425A Method for preparing Baicalin prepn. for external use |
| 01/05/2005 | CN1559413A Freezing-drying powder-injection contg. dexamethasone sodium phosphate, and its prepn. method |
| 01/05/2005 | CN1559400A Method for preparing scutellarein liquid |
| 01/05/2005 | CN1559386A Method for preparing emodin liquid |
| 01/05/2005 | CN1183157C Method for distillig active protein liquid of scorpion |
| 01/05/2005 | CN1183136C Indoloquinazolinones |
| 01/05/2005 | CN1183132C Tetracyclic azepinoindole compounds as 5-HT receptor ligands |
| 01/05/2005 | CN1183122C Dipeptide nitrile cathepsin K inhibitors |
| 01/05/2005 | CN1183107C Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
| 01/05/2005 | CN1182871C Vaccine against intra-cellular pathogens |
| 01/05/2005 | CN1182868C Mutent enterotoxin effective as non-toxic oral adjuvant |
| 01/05/2005 | CN1182863C Chinese herbal medicine for enhancing immunity |
| 01/05/2005 | CN1182844C Use of dialkylfumarates |
| 01/05/2005 | CN1182842C Soft gelatin capsule and its manufacture method |
| 01/04/2005 | US6838574 Induction cell differentiation; leukemia therapy |
| 01/04/2005 | US6838559 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease |
| 01/04/2005 | US6838468 4-(phenyl-piperdin-4-ylidene methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 01/04/2005 | US6838466 Compounds for the treatment of inflammatory disorders |
| 01/04/2005 | US6838458 5-(alkylidene-cycloalkyl)-and 5-(alkylidene-heterocyclyl)-pyrazoles |
| 01/04/2005 | US6838456 Condensed pyridoindole derivatives |
| 01/04/2005 | US6838439 Heterocytes as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 01/04/2005 | US6838433 Peptides used as inhibitors of interleukin-6 (IL-6), for prophylaxis, therapy and/or diagnosis of blood disorders such as leukemia |
| 01/04/2005 | US6838281 Cells expressing fusion proteins of immunoglobulins |
| 01/04/2005 | US6838269 Comprises reduced allergenic variant of enzymatic polypeptide for use in textile treatment and cleaning composition and animal feeds; antiallergens |
| 01/04/2005 | US6838262 Isolated DNA molecule encoding rank ligand |
| 01/04/2005 | US6838261 Nucleic acids encoding anti-CD40 proteins and methods of producing recombinant anti-CD40 proteins |
| 01/04/2005 | US6838260 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 01/04/2005 | US6838093 System for osmotic delivery of pharmaceutically active agents |
| 01/04/2005 | US6838089 Vaccines; immunogens; for Helicobacter infections |
| 01/04/2005 | US6838080 Mixture of a sialic acid binding compound and antigens |
| 01/04/2005 | CA2350854C 1,4-dihydropyridine derivatives and methods of producing the same |
| 12/30/2004 | US20040268424 tissues, organs and cells for use in xenotransplantation |
| 12/30/2004 | US20040267016 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 12/30/2004 | US20040267012 5'-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 12/30/2004 | US20040266873 1-butane acid derivatives pharmaceutical compositions containing said derivatives and the use thereof |
| 12/30/2004 | US20040266839 2'-Methyl-5-(1,3,4-oxadiazol-2-yl)1,1'-biphenyl-4-carboxaide derivatives and their use as p38 kinase inhibitors |
| 12/30/2004 | US20040266826 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors |
| 12/30/2004 | US20040266823 Such as N-[1-(3-phenyl-3-benzoylamino]propyl)-4-piperidinyl]-N-ethylmethanesulfonylphenylacetamide; autoimmune and inflammatory diseases; rheumatoid arthritis; synthesis |
| 12/30/2004 | US20040266782 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 12/30/2004 | US20040266780 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 12/30/2004 | US20040266775 for human, veterinary, or phytoprotective use, e.g., inhibiting the cellular sodium-proton antiporter activity, for the treatment of cardiovascular diseases, metabolic diseases, cancerous diseases or fibrotic diseases |
| 12/30/2004 | US20040266773 Such as 4-(3-methoxyphenyl)-5-methyl-6-(2-fluorobenzyl)-2-(N-(2-pyridyl)ethyl-N -methyl)ethyl-pyridazin-3-one; drugs/prodrugs for treatment of sex-hormone related conditions in men/women |
| 12/30/2004 | US20040266770 treating diseases that are triggered by persistent angiogenesis; inhibition of the VEGF receptor |
| 12/30/2004 | US20040266765 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 12/30/2004 | US20040266764 Hydroxamic acid derivatives |
| 12/30/2004 | US20040266750 Beta-lactamyl vasopressin v1aantagonists |
| 12/30/2004 | US20040266733 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1) |
| 12/30/2004 | US20040266726 yeast-derived ingredient having beta 1,3/1.6 glucan structure (IMMUTOL) or Norwegian Beta Glucan (TM); natural killer cell activating capabilities and tumor angiogenesis inhibiting capability by oral administration |
| 12/30/2004 | US20040266723 Antiviral agents for treatment of Flaviviridae infections |
| 12/30/2004 | US20040266720 Splice-region antisense composition and method |
| 12/30/2004 | US20040266719 immunostimulatory CpG oligonucleotide for inducing a mucosal immune response for treating a subject having an infection comprising enterovirus, calciviridae, vesicular stomatitis, rotavirus infection, Salmonella spp. infection, Helicobacter pyloris infection and M. intracellulare infection |
| 12/30/2004 | US20040266710 Immunotherapy; induce immunology response |
| 12/30/2004 | US20040266709 Immunotherapy; induction immunology response |
| 12/30/2004 | US20040266682 administering gastrin/(cholecystokinin (CCK) receptor ligand and a factor for complementing gastrin for islet neogenesis therapy; sustained release; for expanding a functional beta cell mass of pancreatic islet transplants; reduces amount of stem cells necessary for treatment; kits |
| 12/30/2004 | US20040266676 Preventives/remedies for proliferative organ diseases chronic arthritic diseases. hypertrophic scar or keloid |
| 12/30/2004 | US20040265976 Antigen and lysine acylated protein; cytokines; drug screening; liquid chromatography |
| 12/30/2004 | US20040265960 Antibodies against human IL-21 receptor and uses therefor |
| 12/30/2004 | US20040265913 Tumor necrosis factors (TNF); humanized/chimeric monoclonal antibodies; fab fragments; hybridomas, host cells, Chinese Hamster Ovary cells |
| 12/30/2004 | US20040265891 use in diagnosis and treatment of cancer, neurodegenerative, or immune disorders; antibodies for immunoassays; drug screening |
| 12/30/2004 | US20040265890 a polypeptide of given amino acid sequence; use as drug target for gastrointestinal disorders; fusion proteins; diagnosis |
| 12/30/2004 | US20040265866 Receptor on the surface of activated T-cells: ACT-4 |
| 12/30/2004 | US20040265807 Enzymes |
| 12/30/2004 | US20040265392 Nanoparticles comprising biologically active tnf which is immobilized on the same |
| 12/30/2004 | US20040265382 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
| 12/30/2004 | US20040265380 Orodispersible effervescent tablets |
| 12/30/2004 | US20040265357 Combination of liponic acid and glutamine in food and pharmaceutical products |
| 12/30/2004 | US20040265342 Desensitizing a patient to polypeptide allergen by administering a peptide derived from allergen to induce a late phase response in an individual who possesses major histocompatibility complex Class II molecule; immunotherapy; vaccines |
| 12/30/2004 | US20040265340 Emulsan adjuvant immunization formulations and use |
| 12/30/2004 | US20040265336 Multivalent vaccination using recombinant adenovirus |
| 12/30/2004 | US20040265329 Administering siderophore receptor polypeptides and porins from gram negative microbes, preferably, lipopolysaccarhide for treating mastitis in a milk producing animal |
| 12/30/2004 | US20040265327 Method of immunomodulation using thione-forming disulfides |
| 12/30/2004 | US20040265321 A dimeric fusion protein having two identical polypeptide chains, each chain wtih an extracellular region of an activating Fc gamma R containing an Fc binding site, joined to a molecule that binds an Fc gamma Rn; dimeric fusion protein specifically binds an immune complex |
| 12/30/2004 | US20040265313 Methods to regulate biofilm formation |
| 12/30/2004 | US20040265303 Anti-CCR2 antibodies and methods of use therefor |
| 12/30/2004 | US20040265300 Targeting cancer cell; induction or prevention of apoptosis in eukaryotic cells; a fusion peptide contains a viral apoptotic peptide and an antibody fragment; recombinant host cell comprising the vector, encoding chimeric polypeptide; bioassay monitoring apoptosis activity; drug target |
| 12/30/2004 | US20040265290 Lactic acid bacteria as agents for treating and preventing allergy |
| 12/30/2004 | US20040265276 Medicinal combination useful for in vivo exogenic transfection and expression |
| 12/30/2004 | US20040265270 recombinant; Interferons; stabilized with a polyol, a non-reducing sugar or a amino acid; acetate buffer, albumin; mannitol, saccharose and glycine; storage stability |
| 12/30/2004 | US20040261190 Hydrazono-malonitriles |
| 12/29/2004 | WO2004113523A1 Granzyme b/golgin-160 interaction inhibitor |
| 12/29/2004 | WO2004113451A1 Product of coprecipitation of sparingly soluble substance and water-soluble polymer and process for producing the same |
| 12/29/2004 | WO2004113424A1 Method for preparing coprecipitate of substance sparingly soluble in water and polymer soluble in water |
| 12/29/2004 | WO2004113367A1 Peptide having apoptosis-inhibiting activity |
| 12/29/2004 | WO2004113366A1 Histone deacetylase inhibitor and process for producing the same |
| 12/29/2004 | WO2004113348A1 Thienopyridone derivatives as kinase inhibitors |
| 12/29/2004 | WO2004113344A1 Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same |
| 12/29/2004 | WO2004113343A1 Tricyclic triazolobenzazepine derivative produced as novel crystalline substance |
| 12/29/2004 | WO2004113331A1 Novel compounds that modulate pparϝ type receptors, and use thereof in cosmetic or pharmaceutical compositions |